Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 12, 2025 07:30 ET | Source: Enable Injections, Inc.

Enable Injections Announces enFuse® System Regulatory Approval in Brazil and MRHA Medical Device Registration in the UK

CINCINNATI, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® on-body drug delivery system, announced...
April 25, 2025 13:00 ET | Source: Enable Injections, Inc.

Enable Injections Presents Survey Results Highlighting Missed Opportunities in Subcutaneous Oncology Drug Development at AACR 2025

CINCINNATI, April 25, 2025 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® wearable drug delivery platform, announced...
March 25, 2025 07:30 ET | Source: Enable Injections, Inc.

Enable Injections Announces Regulatory CE Mark Approval in Europe for enFuse Technology

CINCINNATI, March 25, 2025 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® wearable drug delivery platform, today...
September 12, 2024 07:30 ET | Source: Enable Injections, Inc.

Enable Injections Announces Agreement with Sobi® to Develop and Distribute Aspaveli® in Combination with enFuse® in Sobi Territories

CINCINNATI, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® wearable drug delivery platform, and...
May 22, 2024 07:30 ET | Source: Enable Injections, Inc.

Enable Injections Names Matthew Huddleston as Chief Commercial Officer

CINCINNATI, May 22, 2024 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® wearable drug delivery platform today...
May 15, 2024 07:30 ET | Source: Enable Injections, Inc.

Enable Injections and Serina Therapeutics Announce Agreement to Develop SER-252 in Combination with enFuse® for Advanced Parkinson’s Disease

CINCINNATI and HUNTSVILLE, Alabama, May 15, 2024 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® wearable drug...
May 07, 2024 07:30 ET | Source: Enable Injections, Inc.

Enable Injections Expands Strategic Partnership with Roche

CINCINNATI, May 07, 2024 (GLOBE NEWSWIRE) -- Enable Injections, Inc. ("Enable"), a leading innovator in developing and manufacturing the enFuse® platform of wearable drug delivery device technology,...
January 08, 2018 06:00 ET | Source: Enable Injections, Inc.

Enable Injections Achieves ISO 13485:2016 Certification to Meet Mounting Demand for Drug-Delivery Device Combination Products

CINCINNATI, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Enable Injections, Inc., developer of the advanced enFuse™ large volume wearable injectors (LVWI) platform for subcutaneous delivery of biologics, has...
June 07, 2016 06:00 ET | Source: Enable Injections, Inc.

Enable Injections Completes Cincinnati Manufacturing Facility for On Body Delivery Systems

SAN FRANCISCO, June 07, 2016 (GLOBE NEWSWIRE) -- Enable Injections Inc., the developer of wearable medical devices that enable easy, at-home self-administration of high volume injectable drugs and...